BIOPHARMA PROCESS SYSTEMS LIMITED
Get an alert when BIOPHARMA PROCESS SYSTEMS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-31 (in 10mo)
Last made up 2026-03-17
Watchouts
None on the register
Cash
£4M
-17.4% vs 2023
Net assets
£9M
+1.5% vs 2023
Employees
66
+10% vs 2023
Profit before tax
£154K
-89.1% vs 2023
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £14,155,445 | £10,088,840 | |
| Operating profit | — | — | £1,408,711 | £45,990 | |
| Profit before tax | — | — | £1,402,434 | £153,512 | |
| Net profit | — | — | £1,106,907 | £141,705 | |
| Cash | — | — | £5,120,662 | £4,232,170 | |
| Total assets less current liabilities | — | — | £9,816,259 | £10,077,779 | |
| Net assets | — | — | £9,248,747 | £9,390,452 | |
| Equity | — | — | £9,248,747 | £9,390,452 | |
| Average employees | — | — | 60 | 66 | |
| Wages | — | — | £2,757,826 | £2,978,224 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | 10.0% | 0.5% | |
| Net margin | — | — | 7.8% | 1.4% | |
| Return on capital employed | — | — | 14.4% | 0.5% | |
| Current ratio | — | — | 4.02x | 2.81x | |
| Interest cover | — | — | 40.00x | 1.57x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Group structure
- BIOPHARMA PROCESS SYSTEMS LIMITED · parent
- Biopharma Overseas Limited 100%
- Biopharma Technologies SAS 83%
- Biopharma Technology LLC 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RICHARDS, Michael Roy | Secretary | 2009-02-05 | — | British |
| CASSANELLI, Mattia | Director | 2025-12-01 | Aug 1990 | Italian |
| CASTANGIA, Roberto | Director | 2019-01-01 | Jan 1979 | Italian |
| CONWAY, Patrick | Director | 2018-04-06 | May 1974 | British |
| COWEN, Andrew Edward | Director | 2009-02-05 | Feb 1958 | British |
| HOWELLS, Andrew John | Director | 2025-12-01 | May 1967 | British |
| LEWIS, Richard | Director | 2025-12-01 | Jan 1985 | British |
| LOWE, Rupert James Graham | Director | 2009-02-05 | Oct 1957 | English |
| RICHARDS, Michael Roy | Director | 2009-02-05 | Jul 1951 | British |
| WARD, Kevin Richard, Dr | Director | 2016-01-01 | Feb 1970 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GASTER, Anthony John | Secretary | — | 2009-02-05 |
| GASTER, Anthony John | Director | — | 2009-02-05 |
| GASTER, Clare Leonie | Director | — | 2009-02-05 |
| MALLARD, Anne Elizabeth | Director | 1996-08-01 | 2012-09-30 |
| SMITH, Kevin Francis | Director | 2015-01-01 | 2018-04-01 |
| WILLIAMS, Peter Ashley | Director | 2007-01-01 | 2019-06-28 |
| WOOD, Richard Edward | Director | 1997-05-01 | 2014-04-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pe487 Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, right-to-appoint-and-remove-directors-as-trust | 2025-01-03 | Active |
| Kolker Capital Inc. | Corporate entity | Shares 25–50% | 2016-04-06 | Ceased 2020-01-15 |
Filing timeline
Last 20 of 137 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-02-27 | CH01 | officers | Change person director company with change date | |
| 2026-01-16 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-16 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-17 | AA | accounts | Accounts with accounts type full | |
| 2025-03-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-06 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-01-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2024-08-14 | AA | accounts | Accounts with accounts type full | |
| 2024-03-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-07-17 | AA | accounts | Accounts with accounts type full | |
| 2023-04-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-03 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-05-10 | AA | accounts | Accounts with accounts type small | |
| 2022-04-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-13 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2021-06-03 | AA | accounts | Accounts with accounts type small | |
| 2021-05-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-07-27 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-28.7%
£14,155,445 £10,088,840
-
Cash
-17.4%
£5,120,662 £4,232,170
-
Net assets
+1.5%
£9,248,747 £9,390,452
-
Employees
+10%
60 66
-
Operating profit
-96.7%
£1,408,711 £45,990
-
Profit before tax
-89.1%
£1,402,434 £153,512
-
Wages
+8%
£2,757,826 £2,978,224
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers